97 related articles for article (PubMed ID: 8529300)
1. Hemodialyzability of sertraline.
Schwenk MH; Verga MA; Wagner JD
Clin Nephrol; 1995 Aug; 44(2):121-4. PubMed ID: 8529300
[TBL] [Abstract][Full Text] [Related]
2. Effect of hemodialysis on ceftazidime pharmacokinetics.
Nikolaidis P; Tourkantonis A
Clin Nephrol; 1985 Sep; 24(3):142-6. PubMed ID: 3899438
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of ceftriaxone in hemodialysis].
Laville M; Mercatello A; Freney J; Pozet N; Meugnier H; Labeeuw M; Fleurette J; Zech P
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):719-23. PubMed ID: 3309803
[TBL] [Abstract][Full Text] [Related]
5. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
[TBL] [Abstract][Full Text] [Related]
6. The effect of hemodialysis on piperacillin pharmacokinetics.
Heim-Duthoy KL; Halstenson CE; Abraham PA; Matzke GR
Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):680-4. PubMed ID: 3818147
[TBL] [Abstract][Full Text] [Related]
7. Hemodialysis clearance of ethosuximide in patients with chronic renal disease.
Marbury TC; Lee CS; Perchalski RJ; Wilder BJ
Am J Hosp Pharm; 1981 Nov; 38(11):1757-60. PubMed ID: 7304633
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL
J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
[TBL] [Abstract][Full Text] [Related]
9. Comparison of temsirolimus pharmacokinetics in patients with renal cell carcinoma not receiving dialysis and those receiving hemodialysis: a case series.
Lunardi G; Armirotti A; Nicodemo M; Cavallini L; Damonte G; Vannozzi MO; Venturini M
Clin Ther; 2009 Aug; 31(8):1812-9. PubMed ID: 19808140
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
Vanholder R; Camez A; Veys N; Van Loo A; Dhondt AM; Ringoir S
Thromb Haemost; 1997 Apr; 77(4):650-5. PubMed ID: 9134637
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of moxalactam in anuric children and during hemodialysis.
Kaplan SL; Berry PL; Mason EO; Kramer WG
Pediatr Pharmacol (New York); 1983; 3(1):29-36. PubMed ID: 6646877
[TBL] [Abstract][Full Text] [Related]
12. Influence of liver cirrhosis on sertraline pharmacokinetics.
Démolis JL; Angebaud P; Grangé JD; Coates P; Funck-Brentano C; Jaillon P
Br J Clin Pharmacol; 1996 Sep; 42(3):394-7. PubMed ID: 8877033
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of the pharmacology of sertraline.
Warrington SJ
Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 2():11-21. PubMed ID: 1806626
[TBL] [Abstract][Full Text] [Related]
15. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
17. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study.
Pappas P; Karavasilis V; Briasoulis E; Pavlidis N; Marselos M
Cancer Chemother Pharmacol; 2005 Oct; 56(4):358-60. PubMed ID: 15883819
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of anakinra in subjects with different levels of renal function.
Yang BB; Baughman S; Sullivan JT
Clin Pharmacol Ther; 2003 Jul; 74(1):85-94. PubMed ID: 12844139
[TBL] [Abstract][Full Text] [Related]
20. Cerebrovascular effects of hemodialysis in chronic kidney disease.
Prohovnik I; Post J; Uribarri J; Lee H; Sandu O; Langhoff E
J Cereb Blood Flow Metab; 2007 Nov; 27(11):1861-9. PubMed ID: 17406658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
